Government of CanadaPublic Health Agency of Canada / Agence de santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

Volume 29-09
1 May 2003

[Table of Contents]

 

UPDATE TO THE 2002 CANADIAN IMMUNIZATION GUIDE

Typhoid Vaccine 

Page 215, Preparations Licensed for Immunization, Oral live-attenuated vaccine: 

“The vaccine [Ty21a] is produced by Swiss Serum and
Vaccine Institute . . .” 

The corporate name of the Swiss Serum and Vaccine Institute was officially changed in 2002 to Berna Biotech

Page 218, Booster Doses: 

“Nonetheless, periodic booster doses in those at continued risk may reasonably be expected to increase antibody titres and protection (e.g., every 2-3 years for the parenteral formulation and every 3-4 years for the oral formulations).” 

The last interval given in parentheses should be changed to “. . . and every 7 years for the oral formulations).” 

Page 218, Simultaneous Administration with Other Vaccines: 

“The liquid form of the oral typhoid vaccine can be given simultaneously with oral cholera vaccine, and such a combined formulation is now available (Colertif Berna).” 

Such a combined formulation is not now available, and the manufacturer has no plans to make such a product available. 

 

[Previous] [Table of Contents]

Last Updated: 2003-05-01 Top